Home › NCT05424406
Role of Sleep Reactivity in Shift Work Disorder
Recruiting
Sleep Reactivity as a Novel Mechanism in Shift Work Disorder
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Participants must be working a fixed nightshift schedule, operationalized as: a) working at least three night shifts a week, b) shifts must begin between 18:00 and 02:00, and last between 8 to 12 hours, and c) must also plan to maintain the nightshift schedule for the duration of the study * Participants must have Shift Work Disorder, which will be diagnosed based on ICSD-3 criteria * Participants must show circadian misalignment, operationalized as a baseline melatonin onset between 18:00 and 01:00. * Participants must be at least 18 years old Exclusion Criteria: * Insomnia disorder or excessive sleepiness predating the onset of shift work * Termination of nightshift schedule * Presence of other sleep disorders (e.g. obstructive sleep apnea, narcolepsy) determined by standard clinical polysomnography * Diagnosis of bipolar disorder * History of neurological disorders determined by self-report and medical history * Pregnancy * Alcohol use disorder * Illicit drug use via self-report and urine drug screen if reasonable suspicion to test
About the study
The purpose of this project is to test sleep reactivity as an independent cause of Shift Work Disorder (SWD). The primary hypothesis is that those with high sleep reactivity will show persistent SWD symptoms after experimental reduction of circadian misalignment, which will then be mitigated with CBT.
What is being tested
- Active phototherapy (behavioral)
- Control phototherapy (behavioral)
- Cognitive Behavioral Therapy (CBT) (behavioral)
- Sleep education control (behavioral)
Sponsor: Henry Ford Health System · Participants: 150 · Started: Jan 1, 2023
Contact the study team
- Philip Cheng, PhD · Phone: 248-344-7361
- Marleigh Treger, BS · Phone: 248-344-8028
Official record on ClinicalTrials.gov — NCT05424406
Locations in the U.S.
| Michigan | Henry Ford Columbus Medical Center, Novi |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.